Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
3 Results for "
PROTAC CDK9 degrader-14
" in MedChemExpress (MCE) Product Catalog:
Products (3)
3 Results for "PROTAC CDK9 degrader-14" in MCE Product Catalog:
Cat. No.: HY-133617
CAS No.: 2411019-98-0
PROTAC CDK9 degrader-14 is a CDK9 PROTAC degrader that recruits CRBN. PROTAC CDK9 degrader-14 efficiently degrades CDK9 and inhibits cell proliferation in solid tumors and hematological malignancies. PROTAC CDK9 degrader-14 can be used in research related to solid tumors, hematological malignancies and triple-negative breast cancer .
Cat. No.: HY-150946
CAS No.: 1453836-45-7
Research Areas:
CDK9 ligand 2 (compound CDK9 ligand 4) is a CDK9 ligand. CDK9 ligand 2 is used for the synthesis of PROTAC CDK9 degrader-14 (HY-133617) .
Cat. No.: HY-133698
CAS No.: 2914920-52-6
Research Areas:
Lenalidomide-O-C7-COOH is an E3 ligase ligand-linker conjugate that can be used for the synthesis of PROTAC CDK9 degrader-14 (HY-133617).
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
